UNSPSC 51422405: Ciclesonide

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S59502J185. European Medicines Agency schedules Ciclesonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06236MIG. Ciclesonide generally arises in the molecular formula C32H44O7. The term CICLESONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) Most nations schedule ciclesonide under HS 29372900 and SITC 54153.

As of Q4 2014, CICLESONIDE remains the US FDA Preferred Term for this commodity. Ciclesonide bears US NLM identifiers UMLS ID C0907850 and NCI Concept Code C65326. SMILES: O1C2(C3(C(C4C(C(O)C3)C3(C(=CC(=O)C=C3)CC4)C)CC2OC1C1CCCCC1)C)C(=O)COC(=O)C(C)C.

UNSPSC 51422405 Ciclesonide is a Commodity-tier code for a specific pharmaceutical product, but the recent state and local procurement activity tagged under this code does not reflect pharmaceutical purchases. The single available recent opportunity — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 — solicits Naloxone and Safe Drug Deactivation Systems, which fall outside the scope of ciclesonide, an inhaled corticosteroid used primarily in respiratory care. The mismatch between the code's nominal pharmaceutical scope and the actual procurement being tagged suggests either a data classification error or that ciclesonide procurement under this code does not currently generate solicitation activity at the state and local level.

The Seminole County opportunity is the only recent record available under this code. That solicitation seeks annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year term with one-year renewal option. Vendors must include all shipping and delivery costs, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation and general liability insurance. The contract potentially involves FEMA funding and includes a three-month probationary termination clause. No geographic spread or repeat-buyer pattern is evident from the available data. State and local procurement activity under UNSPSC 51422405 shows minimal recent relevant opportunity.